Kailera Therapeutics: Initial Ownership Filing
Ticker: KLRA · Form: 3 · Filed: Apr 16, 2026
Sentiment: neutral
Topics: insider-filing, ownership, form-3
TL;DR
Kailera Therapeutics (KLR) insider Christopher Hite just filed his initial ownership docs. Keep an eye on this one.
AI Summary
On April 16, 2026, Christopher Hite filed an initial statement of beneficial ownership of securities (Form 3) for Kailera Therapeutics, Inc. The filing indicates Hite's ownership of securities in the company. The specific number of shares and dollar amounts are not detailed in this initial filing.
Why It Matters
This Form 3 filing marks the initial public disclosure of beneficial ownership for Christopher Hite in Kailera Therapeutics, Inc., providing transparency on early stakeholders.
Risk Assessment
Risk Level: low — A Form 3 filing is a routine disclosure of initial beneficial ownership and does not inherently indicate significant risk.
Key Numbers
- 2026-04-16 — Filing Date (Date of the initial ownership statement)
Key Players & Entities
- Kailera Therapeutics, Inc. (company) — Issuer of securities
- Christopher Hite (person) — Reporting person, initial beneficial owner
- 0002096997 (company) — CIK for Kailera Therapeutics, Inc.
- 0001814238 (person) — CIK for Christopher Hite
FAQ
What is the purpose of a Form 3 filing?
A Form 3 is an initial statement of beneficial ownership of securities filed by individuals who become a director, officer, or beneficial owner of more than 10% of a class of the issuer's equity securities.
Who is the reporting person in this filing?
The reporting person is Christopher Hite.
What company is this filing related to?
This filing is related to Kailera Therapeutics, Inc.
When was this filing made?
The filing date was April 16, 2026.
Does this filing specify the exact number of shares owned?
No, a Form 3 is an initial statement and typically does not detail the exact number of shares or dollar amounts, but rather indicates the reporting person's status as an owner.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 16, 2026 by Christopher Hite regarding Kailera Therapeutics, Inc. (KLRA). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.